Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)
Guy Ron, Ilan G. Ron, Alexandra Amiel, Shlomit Yust-Katz et al.
Journal
Journal of Neuro-Oncology
Topics
Brain Metastases and Treatment
article
Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)
Guy Ron, Ilan G. Ron, Alexandra Amiel, Shlomit Yust-Katz, Yosef Laviv, Halit Kantor, Andrew A. Kanner, Eyal Fening, Benjamin W. Corn
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Neuro-OncologyVol. 176(2)
Institutions
Ben-Gurion University of the Negev (IL), Hebrew University of Jerusalem (IL), Rabin Medical Center (IL), Barzilai Medical Center (IL), Clalit Health Services (IL), University of Haifa (IL)